Serial Assessment of Immune Status by Circulating CD8+Effector T Cell Frequencies for Posttransplant Infectious Complications

Author:

Uemoto Shinji1,Ozawa Kazue2,Egawa Hiroto1,Takada Yasutsugu1,Sato Hiroshi3,Teramukai Satoshi4,Kasahara Mureo1,Ogawa Kohei1,Ono Masako2,Takai Kenji5,Fukushima Masanori3,Inaba Kayo6,Tanaka Koichi7

Affiliation:

1. Department of Transplantation and Immunology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan

2. Hepatic Disease Research Institute, Kyoto 605-0981, Japan

3. Division of Bioscience, Shiga University of Medical Science, Shiga 520-2192, Japan

4. Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto 606-8507, Japan

5. Division of Cellular Immunology, SRL Inc., Tokyo 192-8535, Japan

6. Division of Systemic Life Science, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan

7. Institute of Biomedical Research and Innovation, Hyogo 650-0047, Japan

Abstract

To clarify the role of CD8+effector T cells for infectious complications, 92 recipients were classified according to the hierarchical clustering of preoperative CD8+CD45 isoforms: Group I was naive, Group II was effector memory, and Group III was effector (E) T cell-dominant. The posttransplant infection rates progressively increased from 29% in Group I to 64.3% in Group III recipients. The posttransplant immune status was compared with the pretransplant status, based on the measure (% difference) and its graphical form (scatter plot). In Groups I and II, both approaches showed a strong upward deviation from pretransplant status upon posttransplant infection, indicating an enhanced clearance of pathogens. In Group III, in contrast, both approaches showed a clear downward deviation from preoperative status, indicating deficient cytotoxicity. The % E difference and scatter plot can be used as a useful indicator of a posttransplant infectious complication.

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Hindawi Limited

Subject

General Medicine,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3